These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 35988850)
21. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function. Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698 [TBL] [Abstract][Full Text] [Related]
22. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient. Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579 [TBL] [Abstract][Full Text] [Related]
23. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis. Smith S; Ratjen F; Remmington T; Waters V Cochrane Database Syst Rev; 2020 May; 5(5):CD006961. PubMed ID: 32412092 [TBL] [Abstract][Full Text] [Related]
24. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006961. PubMed ID: 28628280 [TBL] [Abstract][Full Text] [Related]
25. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277 [TBL] [Abstract][Full Text] [Related]
26. Compensatory evolution of Pseudomonas aeruginosa's slow growth phenotype suggests mechanisms of adaptation in cystic fibrosis. La Rosa R; Rossi E; Feist AM; Johansen HK; Molin S Nat Commun; 2021 May; 12(1):3186. PubMed ID: 34045458 [TBL] [Abstract][Full Text] [Related]